MicroBiopharm Acquired by Gujarat Themis Biosyn | Healthcare M&A Deal

Gujarat Themis Biosyn has acquired MicroBiopharm, a healthcare services other business in Japan. Gujarat Themis Biosyn acquisitions focus on expanding healthcare M&A capabilities through MicroBiopharm acquisition, strengthening the buyer’s presence in Japan-based life science activities. MicroBiopharm is expected to support Gujarat Themis Biosyn’s healthcare services other platform with additional capabilities aligned to healthcare M&A demand. The announced add on acquisition is structured as an add on acquisition, with deal size undisclosed and details on advisors and expected close date not publicly specified.